Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AC5 Topical Gel

K-Number: K182681 · 2018-12-14

Decision Date2018-12-14
Product CodeFRO
DecisionSubstantially Equivalent

Device Summary

AC5 Topical Gel is a medical device manufactured by Arch Therapeutics, Inc.. It received FDA 510(k) clearance on 2018-12-14 under approval number K182681. The device is classified under product code FRO. Product code FRO falls under the category of Anesthesiology, which includes devices for anesthetic delivery and patient monitoring. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AC5 Topical Gel?

AC5 Topical Gel is a medical device that received FDA 510(k) clearance on 2018-12-14. It is manufactured by Arch Therapeutics, Inc.. The 510(k) number is K182681.

When was AC5 Topical Gel approved by the FDA?

AC5 Topical Gel received FDA 510(k) clearance on 2018-12-14, under approval number K182681.

What company makes AC5 Topical Gel?

AC5 Topical Gel is manufactured by Arch Therapeutics, Inc..

What is the FDA product code for AC5 Topical Gel?

The FDA product code for AC5 Topical Gel is FRO. This falls under the Anesthesiology category.

Other Devices by Arch Therapeutics, Inc.

Related Devices (Code: FRO)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.